Fact-checked by Grok 2 weeks ago

Floater

A floater, also known as an eye floater or vitreous floater, is a small, dark shape—such as a spot, thread, squiggly line, or cobweb—that drifts across a person's field of vision, created by shadows cast on the retina by microscopic debris in the eye's vitreous humor.^[1] These shapes become more visible against bright backgrounds, like a clear sky or white wall, and tend to move with eye motion but may seem to dart away when directly viewed.^[1] Floaters are typically harmless and a common part of aging, resulting from natural changes in the vitreous, the clear gel that fills the eye's interior.^[2] The primary cause of floaters is posterior vitreous detachment (PVD), where the vitreous gel shrinks and pulls away from the retina due to age-related syneresis, a process that clumps collagen fibers and cellular debris.^[2] Posterior vitreous detachment becomes common after age 50 (affecting about 50-60%) and affects most people by age 80 (over 80%), with higher prevalence in those who are very nearsighted (myopic), have undergone cataract surgery, or suffer from diabetes.^[3]^[1] Other contributing factors include eye inflammation (uveitis), bleeding from torn retinal blood vessels, eye injuries, or infections, which can introduce additional debris into the vitreous.^[1] While most floaters fade or become less bothersome over time as the brain adapts, a sudden onset or increase in floaters—especially accompanied by light flashes or a shadow/curtain in peripheral vision—may signal a retinal tear or detachment, requiring prompt medical evaluation to prevent vision loss.^[1] Treatment for symptomatic floaters is rarely needed, as individuals often learn to ignore them; however, in severe cases impairing vision, options like laser vitreolysis or vitrectomy surgery to remove the vitreous gel may be considered, though both carry risks such as infection or cataract formation.^[1]^[4] Preventive measures are limited, but regular eye exams are recommended for at-risk groups to monitor vitreous health and detect complications early.^[1]

Overview

Definition and Characteristics

Floaters are small, semi-transparent or shadowy specks, strings, or cobweb-like shapes that appear to drift across the visual field. These visual phenomena arise from shadows cast on the retina by opacities, such as clumps of microscopic collagen fibers or cell debris, within the vitreous humor—the clear, gel-like substance filling the space between the lens and the retina.^[5]^[6]^[2] A key characteristic of floaters is their dynamic movement: they tend to follow the motion of the eyes but with a slight lag, often seeming to dart away when directly fixated, which keeps them persistently within the line of sight. They become most apparent against plain, bright backgrounds, such as a blue sky or white wall, where the contrast enhances their visibility, though they may also be noted during activities like reading.^[5]^[2] The vitreous humor itself is a transparent, avascular gel that occupies about four-fifths of the eye's volume, composed of approximately 99% water along with sparse networks of type II and type IX collagen fibers, hyaluronic acid, and minor components like proteoglycans and salts that maintain its structure. This composition allows the vitreous to provide structural support while permitting light transmission to the retina.^[7]^[2] Floaters have been described since ancient times, with early references in Greek and Roman texts as muscae volitantes ("flying flies"); they were formally recognized in medical literature from the 18th century, with the term myodesopsia (from Greek, meaning "fly-like appearance") coined to describe the perception of these drifting forms. Advancements in 20th-century ophthalmology, including biomicroscopy and vitreoretinal imaging, have refined the understanding of their optical nature.^[8]^[9]

Types of Floaters

Floaters, or vitreous opacities, are categorized morphologically into several distinct types based on their appearance and the underlying structural changes in the vitreous humor. The Weiss ring is an annular, ring-shaped floater that arises from posterior vitreous detachment (PVD), where the posterior hyaloid membrane separates from the optic disc, leaving a visible circular remnant that casts a shadow on the retina.^[10] Linear strands, often described as thread-like or worm-like, result from vitreous syneresis, the age-related aggregation and contraction of collagen fibers within the liquefying vitreous gel.^[2] Diffuse opacities appear as hazy or cloud-like shadows and are typically associated with vitreous hemorrhage, where blood cells disperse throughout the vitreous, or inflammation, leading to widespread protein exudates or cellular debris.^[2] Punctate spots manifest as small, sparkling or granular points, commonly seen in asteroid hyalosis, a benign condition involving calcium-lipid deposits that accumulate unilaterally in the vitreous of older adults, though these rarely cause symptomatic floaters due to their relative immobility.^[11] In addition to morphological classification, floaters are distinguished by their origin, which helps differentiate benign from potentially serious cases. Physiological floaters are the most common and stem from normal age-related vitreous degeneration, beginning around age 50 as the gel liquefies and collagen clumps form without underlying pathology.^[8] Pathological floaters arise from disease processes, such as inflammatory cells or pigment debris in uveitis, where immune-mediated inflammation introduces leukocytes or keratocytes into the vitreous, or from retinal tears releasing blood or tissue fragments.^[5] Iatrogenic floaters occur secondary to ocular interventions, including post-cataract surgery vitreous changes or intravitreal injections that introduce air bubbles, silicone oil droplets, or residual surgical debris into the vitreous cavity.^[12] Specific examples illustrate these categories further. Cobweb-like floaters, resembling delicate webs or nets, emerge during early vitreous liquefaction, where partial gel breakdown creates intricate collagen networks that drift across the visual field.^[8] Ring-shaped floaters from hyaloid remnants, akin to the Weiss ring, represent detached segments of the posterior hyaloid membrane that persist as prominent, mobile opacities following PVD.^[10] Certain types of floaters are notably rare and linked to advanced degenerative conditions. For instance, asteroid hyalosis produces punctate opacities in only about 1-2% of individuals over 60, often without significant visual disturbance, while other degenerative vitreoretinal disorders may yield unusual morphologies like clustered aggregates in conditions such as amyloidosis or advanced syneresis, though these are infrequently reported and typically unilateral.^[13]^[14]

Clinical Presentation

Symptoms

Patients with eye floaters typically perceive small, drifting shapes in their field of vision, such as black or gray specks, strings, threads, squiggly lines, or cobweb-like shadows, which move with eye motion and often dart away when directly fixated.^[5]^[1]^[15] These visual phenomena can occur in the central or peripheral vision and become more noticeable against bright or uniform backgrounds, such as a clear sky or white wall, or during rapid eye movements.^[16]^[17] In individuals with myopia, floaters are more prevalent due to the elongated shape of the eye, though they generally do not obscure central visual acuity and instead primarily cause visual distraction or annoyance during daily activities like reading or driving.^[18] Over time, many people experience some degree of brain adaptation, where the perception of floaters becomes less bothersome as the visual system learns to ignore them, although adaptation varies by individual and floater density.^[19] Floaters may develop gradually with age-related vitreous changes or appear more abruptly, persisting indefinitely but often fading in prominence for some without affecting overall visual function.^[5] Associated non-visual effects are uncommon but can include mild eye strain from heightened awareness of the drifting shapes; benign floaters themselves do not cause pain.^[15]

Warning Signs and Complications

A sudden increase in the number of floaters, often described as a shower of new spots or specks in the visual field, serves as a critical warning sign that may indicate an underlying retinal issue.^[20] This symptom, when acute, warrants immediate evaluation to rule out serious pathology. Accompanying photopsia, or sudden flashes of light, particularly in peripheral vision, further heightens concern, as it frequently signals vitreoretinal traction leading to potential retinal damage.^[21] Additionally, the appearance of a shadow, curtain, or veil obscuring part of the visual field represents an urgent indicator of possible retinal detachment, requiring prompt ophthalmologic intervention to prevent permanent vision loss.^[22] Potential complications from these warning signs include progression to retinal breaks, with studies reporting a prevalence of approximately 8-14% in patients presenting with acute floaters and flashes, often associated with posterior vitreous detachment.^[23] Vitreous hemorrhage can also arise, particularly if a retinal tear disrupts blood vessels, leading to sudden vision obscuration through blood accumulation in the vitreous cavity and risking further complications like proliferative vitreoretinopathy.^[24] In cases involving inflammation, such as uveitis, floaters can result from inflammatory cells in the vitreous, while secondary glaucoma may develop separately due to anterior chamber inflammation obstructing aqueous outflow or from corticosteroid treatment, potentially elevating intraocular pressure and causing optic nerve damage if untreated.^[25] In emergency scenarios, these symptoms typically evolve rapidly over hours to days, contrasting with benign floaters that remain stable or gradually fade over weeks to months.^[26] Patients should be educated to monitor for any worsening or new changes in floaters, flashes, or visual field defects, seeking immediate care if they occur; research indicates that while about 86% of acute cases resolve without intervention, roughly 14% involve retinal pathology necessitating further assessment.^[23]

Pathophysiology

Vitreous Changes

Vitreous syneresis represents the primary age-related degenerative change in the vitreous humor, characterized by the progressive liquefaction of its gel-like structure. This process involves the formation of fluid-filled pockets (lacunae) within the vitreous, which cause the surrounding collagen fibrils to aggregate and collapse into dense clumps known as opacities. These opacities cast shadows on the retina, manifesting as floaters in the visual field. Syneresis typically begins in the central and posterior vitreous and is a normal physiological phenomenon that contributes to the majority of benign floaters in otherwise healthy eyes.^[2] The biochemical underpinnings of syneresis stem from the degradation of key structural components in the vitreous matrix. Hyaluronic acid, which maintains the gel's hydration and viscosity, undergoes enzymatic breakdown by hyaluronidases, leading to reduced molecular weight and loss of water-binding capacity. Concurrently, collagen fibrils—primarily types II and IX—experience weakening of cross-links due to oxidative stress from reactive oxygen species and proteolytic enzymes such as matrix metalloproteinases. These changes destabilize the collagen-hyaluronic acid network, promoting phase separation into liquid and solid phases.^[27]^[28] Syneresis progresses through distinct stages, initiating with the development of small posterior vitreous pockets of liquefaction, often in the fourth or fifth decade of life, which gradually expand and lead to focal opacification as collagen condenses. Early changes may be subclinical, but as pockets coalesce, visible floaters emerge. The prevalence of significant syneresis and associated floaters rises markedly with age. This age-dependent progression reflects cumulative biochemical wear on the vitreous scaffold.^[29]^[30] Non-pathological variants of vitreous changes include gradual, uniform shrinkage of the vitreous gel without forming prominent pockets or opacities, representing a benign adaptation to aging rather than a disruptive degeneration. In such cases, the vitreous maintains sufficient structural integrity to avoid symptomatic floaters, though subtle alterations in transparency may occur over time. These physiological shifts are distinct from more pronounced syneresis and do not typically require intervention.^[2]

Posterior Vitreous Detachment

Posterior vitreous detachment (PVD) occurs when the posterior vitreous cortex separates from the internal limiting membrane of the retina, a process driven by age-related vitreous shrinkage and liquefaction known as syneresis.^[3] The vitreous gel, which normally adheres firmly to the retina via its cortex, undergoes contraction that exerts traction, leading to detachment typically beginning at the optic disc or macula. This separation often results in the formation of a Weiss ring, a visible annular opacity created by the condensed vitreous remnants around the optic disc that appears as a prominent floater in the visual field.^[10]^[31] PVD affects approximately 66% of individuals between the ages of 66 and 86, with prevalence increasing to about 24% in the 50-59 age group, 37% in the 60s, 59% in the 70s, and up to 87% by the 80s; postmortem studies confirm its high prevalence in older demographics.^[3]^[30] Most cases are asymptomatic, but symptomatic PVD manifests as noticeable floaters due to the sudden release of opacities into the visual axis. The condition is more common in eyes with predisposing factors such as high myopia, where earlier onset and stronger vitreoretinal adhesions increase susceptibility.^[10] A key concern with PVD is the risk of complications from vitreoretinal traction, with approximately 22% of symptomatic cases developing a retinal tear (based on meta-analysis), potentially leading to rhegmatogenous retinal detachment if untreated.^[32] This risk rises significantly in patients with high myopia, where the elongated globe and thinner retina amplify tractional forces during detachment.^[33] In most instances, PVD follows a benign natural history, with symptoms such as floaters and photopsias typically resolving or becoming less bothersome within 3-6 months as the vitreous settles and the brain adapts to the visual changes.^[34] Complete resolution of floaters occurs in many patients over this period, though some persistent opacities may remain without impacting visual function.^[35]

Other Ocular Associations

Floaters can arise in association with retinal detachment, where the sudden onset of numerous floaters often results from the release of blood cells or pigment granules into the vitreous humor due to retinal tears, signaling a heightened risk of rhegmatogenous retinal detachment if untreated.^[36]^[37]^[2] This mechanism occurs as traction from vitreous separation disrupts the retinal pigment epithelium, dispersing melanin-laden cells or causing minor hemorrhages that manifest as dark spots or webs in the visual field.^[38] Early recognition of such floaters is critical, as up to 14% of cases involving acute posterior vitreous changes may progress to retinal tears leading to detachment.^[26] Inflammatory conditions of the eye, such as uveitis, frequently produce floaters through the accumulation of inflammatory cells and debris within the vitreous cavity, particularly in intermediate uveitis where painless floaters are a hallmark symptom.^[39]^[40]^[41] Similarly, endophthalmitis, a severe intraocular infection, generates cellular exudates and opacities that appear as sudden floaters, often accompanied by vision loss and pain.^[42] Asteroid hyalosis, characterized by calcium-containing crystalline deposits in the vitreous, represents another inflammatory or degenerative association, with a prevalence of approximately 1-2% in the elderly population, though many cases remain asymptomatic due to the static nature of the opacities.^[43]^[44] Traumatic or iatrogenic events can also trigger floaters via vitreous hemorrhage, where blood from disrupted retinal vessels diffuses into the vitreous, creating diffuse or clustered opacities perceived as moving shadows or spots.^[24] Following cataract surgery, new-onset floaters occur in up to 12-20% of patients, typically arising from transient vitreous instability or minor bleeding during the procedure.^[45]^[46] Rarely, floaters may signal underlying ocular tumors, such as choroidal melanoma, where tumor growth or associated hemorrhage leads to vitreous seeding and visual disturbances in about 7% of cases.^[47]^[48] In diabetic retinopathy, neovascularization promotes fragile vessel proliferation on the retina or optic disc, which can rupture and cause vitreous hemorrhage manifesting as prominent floaters, often indicating progression to the proliferative stage.^[49]^[50]

Diagnosis

Patient History and Examination

The initial assessment of patients presenting with eye floaters begins with a detailed history to characterize the symptoms and identify potential underlying causes. Key elements include the onset of symptoms, distinguishing between sudden appearance—which may indicate posterior vitreous detachment or retinal tear—and gradual development, often associated with age-related vitreous degeneration. Patients are questioned about the number, size, shape, and location of floaters, such as whether they appear as single spots, webs, or clusters drifting in the central or peripheral visual field, and any changes over time. Associated symptoms like photopsias (flashes of light), sudden vision loss, or a curtain-like shadow across the vision are critical to elicit, as they raise concern for retinal detachment. Risk factors such as recent ocular trauma, high myopia, previous eye surgery, or systemic conditions like diabetes are also explored to contextualize the presentation.^[2]^[51] The physical examination focuses on basic ophthalmic evaluation to rule out serious pathology without advanced imaging. Visual acuity is measured using a Snellen chart in each eye separately to detect any reduction that might suggest macular or retinal involvement. A comprehensive slit-lamp biomicroscopic examination of the anterior segment is performed to assess for inflammation or other abnormalities, followed by pupil dilation with mydriatic agents to enable indirect ophthalmoscopy or fundus biomicroscopy for direct visualization of vitreous opacities and the posterior segment. This allows identification of Weiss rings indicative of posterior vitreous detachment or peripheral retinal tears. If central vision distortion is suspected, an Amsler grid test may be used to evaluate for macular involvement by checking for wavy lines or scotomas in the central field.^[4]^[52]^[10] Differential diagnosis during history and examination involves distinguishing floaters from non-ocular phenomena based on symptom patterns; for instance, persistent drifting opacities suggest vitreous debris, whereas transient zigzag or scintillating lights point toward migraine aura, which typically lasts 5-60 minutes and resolves without permanent visual defects. Neurological issues, such as transient ischemic attacks, are considered if symptoms are unilateral and accompanied by other focal deficits, but the absence of headache or patterned visual hallucinations helps differentiate them. Standard protocols emphasize urgent referral to an ophthalmologist for dilated fundus examination if floaters are acute (onset within days to weeks), numerous, or accompanied by flashes or visual field defects, ideally within 24-48 hours to prevent progression to retinal detachment. In stable, chronic cases without red flags, routine monitoring suffices.^[37]^[51]

Imaging and Tests

Optical coherence tomography (OCT) provides high-resolution cross-sectional imaging of the vitreoretinal interface, enabling the detection of subtle vitreous opacities and subclinical posterior vitreous detachments associated with floaters.^[53] In patients presenting with acute symptomatic floaters, OCT can identify premacular vitreous opacities or other changes suggestive of underlying retinal tears, particularly in cases of posterior vitreous detachment.^[54] This non-invasive modality has become an emerging standard for evaluating the posterior segment when floaters indicate potential vitreoretinal pathology.^[53] B-scan ultrasonography is particularly valuable when vitreous opacities or hemorrhage obscure the fundus view, allowing visualization of the vitreous structure, retinal detachment, or masses such as tumors.^[55] It effectively identifies vitreous hemorrhage, a common cause of sudden floaters, by demonstrating echogenic material within the vitreous cavity, and can differentiate it from other pathologies like choroidal tumors or retinal elevations.^[24] This technique is noninvasive and essential for assessing media opacities that prevent direct ophthalmoscopic examination.^[56] Fundus photography documents retinal abnormalities linked to floaters, such as tears or detachments, providing a baseline record for monitoring progression.^[57] Fluorescein angiography complements this by highlighting vascular leakage or staining indicative of retinal tears or inflammatory conditions, such as uveitis, that may contribute to floater symptoms.^[58] As of 2025, wide-field retinal imaging has emerged as a key tool for peripheral assessment in floater evaluation, offering up to 97% sensitivity for detecting retinal tears when combined with steered imaging techniques.^[59] This modality captures a broader retinal field than traditional methods, improving identification of peripheral pathologies associated with vitreous changes.^[60]

Management

Observation and Lifestyle Advice

For most individuals with benign eye floaters, observation, also known as watchful waiting, is the recommended primary management strategy, as these opacities typically do not impair visual acuity or lead to complications over time.^[4] The rationale stems from the natural course of floaters, where the brain often adapts to their presence, rendering them less noticeable; clinical experience indicates that many patients report diminished perception within months, though exact timelines vary.^[37] Intervention is generally deferred because the risks of procedures, such as infection, retinal tears, or cataracts, outweigh potential benefits in uncomplicated cases, where floaters do not progress to vision-threatening conditions.^[4]^[8] Lifestyle adjustments can help minimize the perceived impact of floaters without altering their physical presence. Patients are advised to reduce eye strain by limiting prolonged screen time and taking regular breaks, such as following the 20-20-20 rule (every 20 minutes, look 20 feet away for 20 seconds).^[16] Using adequate ambient lighting, such as adjusting room illumination or employing task lamps, can make floaters less prominent against bright backgrounds, while wearing sunglasses outdoors filters intense light that may accentuate their visibility.^[61] Techniques to ignore floaters, like shifting focus to the task at hand rather than tracking the shadows, promote adaptation and reduce fixation-related anxiety.^[62] Monitoring involves educating patients on warning signs that necessitate prompt reevaluation, including a sudden increase in floaters, new flashes of light, or peripheral vision shadows, which could indicate retinal issues.^[1] For high-risk cases, such as recent posterior vitreous detachment or high myopia, regular follow-up examinations are advised at 1-3 months post-onset to ensure no progression, with dilated fundus exams to assess the retina.^[63] Evidence from cohort studies supports this approach, showing that in uncomplicated floaters without associated tears, there is no significant vision loss or deterioration over follow-up periods of up to several years.^[64]

Non-Surgical Interventions

Non-surgical interventions for eye floaters primarily involve laser vitreolysis, pharmacological approaches, and emerging nutritional strategies aimed at providing symptomatic relief in cases where observation is insufficient. Laser vitreolysis uses a neodymium-doped yttrium aluminum garnet (Nd:YAG) laser to target and vaporize or fragment large, central vitreous opacities, thereby reducing their visual interference. This outpatient procedure is typically performed in sessions lasting 10-20 minutes, with multiple sessions often required for optimal results. Studies indicate efficacy in select patients, with approximately 50-90% experiencing a reduction in floater density and improved visual quality, particularly for Weiss ring or asteroid hyalosis-type floaters located away from the macula and lens.^[65]^[66] However, success depends on floater characteristics, as smaller or peripheral opacities may fragment without resolution, leading to variable outcomes across patient cohorts.^[67] Potential risks of laser vitreolysis include cataract formation (reported in 2-5% of cases, often due to inadvertent lens capsule disruption), elevated intraocular pressure, retinal tears, and rare instances of retinal detachment or hemorrhage. These complications underscore the importance of precise laser energy delivery and thorough pre-procedure evaluation, including fundus examination and optical coherence tomography to exclude contraindications like recent retinal pathology. Patient satisfaction rates post-treatment can reach 92% for symptom alleviation, though not all achieve complete resolution.^[66]^[19]^[68] Pharmacological options remain limited but include low-dose atropine (0.01%) eye drops, which induce mild pupil dilation to shift floaters peripherally out of the central visual axis, thereby lessening their perceptual impact. Recent 2025 studies confirm this off-label use as safe and noninvasive, with significant symptom improvement in 54-64% of patients after 4-6 weeks of twice-daily application, without notable side effects like prolonged cycloplegia in low concentrations. Anti-inflammatory agents, such as corticosteroids, may be employed adjunctively for floaters associated with uveitis to reduce underlying inflammation, though evidence for direct floater resolution is anecdotal.^[69]^[70]^[71] Nutritional interventions represent an emerging non-invasive approach, with a double-blind placebo-controlled trial demonstrating that a targeted micronutrient supplement (containing L-lysine, vitamin C, grape seed extract, zinc, and hesperidin) reduced floater symptoms in 77% of participants and improved vision-related quality of life in 67% after 6 months. While supportive rather than curative, this option may aid adaptation in mild cases.^[72] Enzyme-based interventions, such as intravitreal ocriplasmin injections, target posterior vitreous detachment (PVD) induction to alleviate floaters linked to vitreomacular traction. Clinical trials demonstrate PVD rates of 13-16% post-injection, with potential floater reduction in responsive cases, though primarily approved for traction rather than isolated floaters. As of 2025, refined laser protocols emphasize lower energy pulses and advanced imaging guidance to minimize complications, while ocriplasmin trials explore expanded indications for floater management in non-traction settings. These interventions are reserved for patients with debilitating, persistent symptoms unresponsive to conservative measures, ensuring benefits outweigh risks through careful selection based on floater size, location, and visual impairment severity.^[73]^[74]^[75]

Surgical Treatments

Surgical treatments for floaters primarily involve pars plana vitrectomy (PPV), an invasive procedure reserved for cases where symptoms severely impair vision or quality of life. This surgery removes the vitreous humor and associated opacities through small incisions in the pars plana region of the eye, aiming to alleviate persistent visual disturbances caused by large or numerous floaters. PPV is not recommended as a routine intervention due to its potential complications, but it offers substantial relief for carefully selected patients.^[76] Indications for PPV include monocular vision impairment from floaters that significantly affects daily activities, or cases where psychological distress is profound and unresponsive to conservative measures. It is particularly considered when floaters result from posterior vitreous detachment (PVD) and lead to debilitating symptoms, such as reduced contrast sensitivity or overlaying central vision. Surgeons typically evaluate candidates through comprehensive ophthalmic assessment to ensure the benefits outweigh the risks, avoiding surgery in bilateral cases or when symptoms are mild.^[77]^[78] The procedure is performed under local or general anesthesia as an outpatient operation in most instances. Micro-incisions are made in the sclera using 23- to 27-gauge instruments, allowing transconjunctival access without sutures for minimally invasive removal of the vitreous gel and floaters via a vitrectomy probe. Core vitrectomy targets the central vitreous, often followed by peripheral trimming to reduce recurrence risk; gas tamponade may be used if retinal issues are present, though it is not routine for isolated floaters. The entire process typically lasts 30-60 minutes per eye, with rapid visual recovery in uncomplicated cases.^[79]^[80] PPV demonstrates high efficacy, with symptom relief reported in 90-95% of patients, including full resolution of floaters and improved contrast sensitivity in the majority. However, risks include retinal detachment in 1-5% of cases, elevated intraocular pressure (approximately 1.5%), and vitreous hemorrhage (around 2%). Cataract acceleration is common, necessitating surgery in 25-80% of phakic eyes within 1-4 years post-procedure. Overall complication rates remain low with modern techniques, but patients must be counseled on these potential outcomes.^[76]^[81]^[82] Historically, PPV evolved from open-sky vitrectomy techniques described in 1969 to the standardized pars plana approach introduced by Robert Machemer in 1971 using 20-gauge instruments. Initial applications focused on retinal disorders, with elective use for floaters emerging in the late 1990s and first major publications around 2000. Advancements to smaller-gauge systems in the 2000s, including 23- and 27-gauge probes, have minimized trauma, improved safety, and expanded feasibility for floater-specific cases.^[83]^[84]^[85]

Epidemiology and Risk Factors

Prevalence and Demographics

Floaters, or vitreous opacities, affect a significant portion of the adult population worldwide. A large community survey of smartphone users found that 76% of respondents reported observing floaters, with prevalence consistent across age groups but increasing in perceived severity with age.^[86] The prevalence of posterior vitreous detachment (PVD), the primary cause of floaters, increases with age, affecting about 24% of individuals aged 50-59, around 60% aged 60-70, and up to 87% over 80.^[3]^[87] Prevalence is notably higher among individuals with myopia, who may experience floaters at a younger age due to elongated axial length weakening vitreoretinal adhesions.^[88] A questionnaire-based study among medical students reported an overall floater prevalence of 37.8%, with myopia identified as the predominant associated refractive error.^[89] Demographic trends show floaters becoming more frequent in females following menopause, linked to estrogen decline affecting vitreous stability.^[90] Ethnic variations appear minimal, as floater reports do not differ significantly by race.^[86] However, higher reporting occurs in developed countries, attributable to increased health awareness and access to eye care.^[91] A 2025 knowledge, attitudes, and practices (KAP) study found that 53.7% of respondents would seek immediate medical attention for visual abnormalities, indicating potential underreporting in low-awareness populations.^[91] Longitudinal data from the Blue Mountains Eye Study in Australia revealed a 49.8% prevalence of significant vitreoretinal interface abnormalities, including those associated with floaters, at the 15-year follow-up in an older cohort.^[92] These findings underscore the progressive nature of floaters as a common age-related phenomenon.

Associated Risk Factors

Risk factors for the development or severity of eye floaters, primarily linked to posterior vitreous detachment (PVD), are divided into non-modifiable and modifiable categories. Non-modifiable factors include advanced age, high degrees of myopia, and genetic predisposition. Age over 50 years significantly elevates the risk, as the vitreous gel naturally undergoes syneresis and detachment from the retina, with PVD occurring in over 50% of individuals by this age.^[5] High myopia exceeding -6 diopters approximately doubles the risk of PVD by age 60, with complete detachment observed in about 74% of highly myopic eyes in the 60-69 age group compared to roughly 44% in non-myopic eyes; this is attributed to elongated axial length weakening vitreoretinal adhesions.^[93] Family history of PVD or associated retinal tears further increases susceptibility, indicating a hereditary influence on vitreous structure and detachment propensity.^[94] Modifiable risk factors encompass lifestyle and medical conditions that can accelerate vitreous changes. Smoking promotes oxidative damage to ocular tissues, including the vitreous, thereby heightening floater formation through impaired circulation and inflammation.^[95] Diabetes contributes via vascular alterations and potential retinopathy, where hyperglycemic damage leads to vitreous hemorrhage or debris manifesting as floaters, with affected individuals showing higher incidence rates.^[96] Prior eye surgery, such as cataract extraction, or ocular trauma disrupts the vitreous integrity, prompting earlier PVD and increased floater visibility.^[97] Recent cohort studies as of 2025 highlight emerging associations, including ultraviolet (UV) exposure, which may induce vitreous liquefaction and exacerbate floaters through free radical formation.^[98] Poor diet has been linked to greater floater severity in interventional cohorts, where nutrient deficiencies correlate with reduced vitreous stability and visual discomfort.^[99] Obesity indirectly elevates risk via chronic systemic inflammation, which can extend to ocular tissues and promote vitreous opacities.^[100]

Impact and Research

Psychological and Quality of Life Effects

Symptomatic vitreous floaters impose a notable psychological burden on affected individuals, with studies indicating elevated levels of anxiety and depression, particularly among those with severe symptoms. Patients often experience heightened health anxiety stemming from fears that floaters signal impending blindness or other serious ocular pathology, exacerbating emotional distress despite the benign nature of most cases. For instance, research has documented significantly higher scores on standardized depression and anxiety scales in floater patients compared to healthy controls, with symptomatic individuals reporting enhanced depressive symptoms and state/trait anxiety.^[101]^[102]^[103]^[104] The impact on quality of life is quantifiable through validated instruments like the National Eye Institute Visual Function Questionnaire-25 (VFQ-25), where symptomatic patients score approximately 20 points lower on average (73.2 ± 15.6) than age-matched controls (93.9 ± 8.0), reflecting diminished visual functioning and overall well-being. Qualitative investigations further highlight patient-reported challenges, including persistent eye strain that disrupts concentration and leads to avoidance of visually demanding tasks such as driving or reading. These effects underscore a gap in traditional assessments, as floaters contribute to broader psychosocial strain beyond mere visual acuity.^[105]^[106] Socially, floaters can hinder professional and recreational activities, with interference most pronounced in occupations requiring sustained visual focus, such as piloting or driving, where they may reduce productivity and confidence. Patients also describe limitations in hobbies like sports or arts, leading to social withdrawal and a sense of invalidated personal roles, effects that remain underrecognized in epidemiological surveys focused on prevalence rather than subjective burden.^[107]^[108] Adaptation to floaters varies widely, with approximately 40% of individuals achieving full habituation over time through neuroadaptation, allowing the brain to filter out the opacities effectively. However, a minority—estimated at around 10% based on treatment-seeking patterns—endure persistent distress that motivates pursuit of interventions, highlighting the need for personalized support in non-habituating cases.^[109]^[110]

Ongoing Research and Developments

Recent studies in 2025 have focused on improving patient awareness and quality of life assessments for vitreous floaters. A knowledge, attitudes, and practices (KAP) survey conducted among patients with floaters revealed significant gaps in understanding symptoms and treatment options, highlighting the need for targeted education in ophthalmic care.^[91] Similarly, a qualitative study involving 44 semi-structured interviews identified 646 quality-of-life issues across 11 domains, including activity limitations and emotional well-being, underscoring the intermittent visual disruptions caused by floaters and informing the development of floater-specific patient-reported outcome measures to guide clinical guidelines.^[106] Therapeutic research emphasizes less invasive vitreolysis approaches. Nanoparticle-based therapies, such as gold nanoparticles activated by low-energy lasers to target collagen aggregates, have shown promise in preclinical models by reducing floater opacities without damaging surrounding retinal tissue, with ongoing efforts to refine delivery for clinical translation.^[111] Diagnostic innovations leverage artificial intelligence to improve early detection. AI-enhanced optical coherence tomography (OCT) algorithms have achieved high sensitivity in identifying posterior vitreous detachment stages associated with floater formation, enabling proactive monitoring with reported detection rates exceeding 90% in validation datasets.^[112] Ongoing research addresses key evidence gaps, including long-term outcomes of vitrectomy for floaters. A 2025 analysis of pars plana vitrectomy in 308 patients (410 eyes) reported complication rates of 7.3%, with 29.9% of patients electing contralateral procedures indicating satisfaction.^[81] Epidemiological studies are expanding to underrepresented populations, revealing lower treatment access among non-White groups due to barriers in eye care equity, prompting calls for inclusive cohort designs.

Floaters in Animals

Occurrence in Veterinary Medicine

Vitreous floaters, resulting from degeneration of the vitreous humor, occur commonly in mammalian species, particularly as an age-related change. In dogs, vitreous degeneration manifests as liquefaction and opacification of the vitreous gel, leading to visible floaters detectable via ophthalmoscopy or ultrasonography. A study of 114 eyes from normal dogs found vitreous degeneration in 20% of eyes on ultrasonographic examination, with prevalence increasing with age (odds ratio = 6.7 for dogs 7+ years compared with 0-6 years).^[113] A separate study of 200 dogs reported that each additional year of age raises the likelihood of vitreous degeneration by approximately 24%.^[114] This condition is especially noted in older dogs of larger breeds, such as Labradors, where geriatric individuals over 8 years old show notable incidence due to progressive syneresis. In cats, vitreous floaters similarly arise from age-related collagen fibril condensation within the vitreous, appearing as mobile opacities during fundoscopic evaluation, though specific prevalence data are limited compared to canines. Horses also experience vitreous floaters frequently, often linked to trauma or recurrent inflammation, with degeneration presenting as liquefaction and floating debris in the vitreous cavity. Species-specific differences in eye anatomy influence the occurrence of floaters. Birds possess a vitreous humor, but its structure is adapted with a more fluid consistency and the presence of the pecten oculi—a vascular extension into the vitreous—which may contribute to rarer instances of degenerative floaters compared to mammals. Fish eyes include a vitreous body filling the posterior chamber, though its composition varies by species and lacks the gel-like density seen in higher vertebrates, potentially reducing the propensity for syneresis-related floaters. These anatomical variations highlight how floaters are less prevalent or differently manifested in non-mammalian species. The pathophysiology of floaters in animals parallels that in humans, involving vitreous syneresis where the gel liquefies and contracts, forming aggregates that cast shadows on the retina. In non-human primates, such as rhesus monkeys, age-related syneresis is evident, with various degrees observed in 93% of eyes across 15 individuals, mirroring human posterior vitreous changes. In livestock, including horses and cattle, inflammatory processes often precipitate floaters; for instance, equine recurrent uveitis leads to vitritis with clumping of inflammatory cells and debris, resulting in filamentous or membranous opacities in the vitreous. Veterinary studies indicate a prevalence of 15-25% for vitreous floaters in geriatric pets overall, with higher rates in specific cohorts: approximately 20% in aging dogs and up to 43% of eyes in geriatric horses from a survey of 83 animals. These findings underscore the commonality in companion and large animals, driven primarily by senescence and secondary insults like trauma or inflammation.

Management in Animals

In veterinary ophthalmology, diagnosis of vitreous floaters in animals typically involves dilated fundus examinations, which are often performed under sedation or anesthesia to facilitate patient cooperation and thorough visualization of the posterior segment. B-scan ultrasonography is the preferred imaging modality for assessing vitreous opacities, as it effectively detects degenerative changes such as multiple small, motile echoes within the vitreous cavity, even in uncooperative patients; optical coherence tomography (OCT), while useful in humans, is less commonly employed due to the challenges of maintaining animal stillness during the procedure.^[113]^[115]^[116] Management strategies prioritize observation for most benign cases of vitreous floaters, as these opacities rarely cause significant visual impairment and often remain stable without intervention. Surgical options, such as pars plana vitrectomy, are reserved for severe or vision-threatening instances, including trauma-related opacities; this procedure is more frequently considered in large animals like horses, where it has been used to address vitreous involvement in conditions such as recurrent uveitis. Laser vitreolysis, though effective in human patients for disrupting floaters, is rarely pursued in veterinary practice owing to the high cost of equipment and limited accessibility in clinical settings.^[117]^[118]^[119] Species-specific approaches tailor interventions to underlying etiologies and breed predispositions. In dogs, particularly those with uveitis-associated floaters, treatment commonly includes topical or systemic anti-inflammatory agents such as corticosteroids (e.g., prednisolone acetate) or nonsteroidal anti-inflammatory drugs to reduce inflammation and alleviate secondary effects on the vitreous. Prophylactic retinal examinations are advised in breeds prone to myopia or vitreous degeneration, such as Bichon Frises and Boston Terriers, to monitor for progression to complications like retinal detachment.^[120]^[121]^[122] Outcomes for vitreous floaters in animals are generally favorable, with many cases showing stability or partial resolution without active intervention, particularly in older pets where floaters are often incidental findings. Surgical interventions like vitrectomy carry risks, including endophthalmitis, which may be elevated in exotic species due to anatomical challenges and postoperative care difficulties; however, when underlying issues are absent, the prognosis remains good with preserved vision in the majority of patients.^[122]^[118]

References

[1]
Floaters - National Eye Institute - NIH
Nov 18, 2016 · Floaters are small dark shapes that float across your vision. They can look like spots, threads, squiggly lines, or even little cobwebs.
[2]
Vitreous Floaters - StatPearls - NCBI Bookshelf
Vitreous floaters are microscopic collagen fibers within the vitreous that tend to clump and cast shadows on the retina, appearing as floaters to the patient.
[3]
Eye floaters - Symptoms and causes - Mayo Clinic
Jul 2, 2024 · Eye floaters are spots in your vision. They may look to you like black or gray specks, strings, or cobwebs. They may drift about when you move your eyes.
[4]
Eye floaters: MedlinePlus Medical Encyclopedia
Nov 8, 2023 · They are made up of bits of cell debris that drift around in the fluid (vitreous) in the back of your eye. Floaters may look like spots, specks, ...Missing: definition | Show results with:definition
[5]
Proteomic Analyses of the Vitreous Humour - PMC - PubMed Central
It is comprised almost entirely of water (99%) with the remainder consisting of a mixture of collagen fibres, hyaluronic acid, hyalocytes, inorganic salts, and ...
[6]
Eye Floaters: What They Are, Causes & Treatment - Cleveland Clinic
Eye Floaters (Myodesopsias) Eye floaters happen when your vitreous humor (fluid) changes its thickness. This causes you to see squiggly lines or threads.
[7]
Posterior Vitreous Detachment - EyeWiki
Sep 19, 2025 · Floaters may continue indefinitely although they usually gradually diminish over time.Missing: morphology | Show results with:morphology
[8]
Asteroid Hyalosis (AH) - EyeWiki
Sep 18, 2025 · Can cause visual disturbances, including floaters or reduced visual acuity, especially if opacities are numerous or mobile. Ultrasound ...Disease Entity · Risk Factors · Diagnosis · Diagnostic Procedures
[9]
The pathologist's perspective on vitreous opacities | Eye - Nature
Mar 14, 2008 · Acquired causes of vitreous opacity can be categorized as genetic, inflammatory non-infectious, inflammatory infectious, inflammatory iatrogenic ...Introduction · Cellular Vitreous Samples · Inflammatory, Infectious...Missing: physiological | Show results with:physiological
[10]
Asteroid Hyalosis - StatPearls - NCBI Bookshelf
Asteroid hyalosis is benign and does not cause any complications. However, some cases may develop dense AH and cause troublesome floaters, which may need ...
[11]
Floaters & spots | AOA - American Optometric Association
Because they are in your eyes, they move as your eyes move and seem to dart away when you try to look at them directly. Floaters and spots rarely affect vision.
[12]
Eye Floaters: Causes, Symptoms, and Treatment - WebMD
May 9, 2024 · Many floaters happen from age-related changes in your eye's vitreous. See a doctor as soon as you notice eye floaters that don't go away or if ...
[13]
Mayo Clinic Minute: What are eye floaters?
Jan 16, 2023 · Eye floaters are a symptom of age, according to Dr. Amir Khan, a Mayo Clinic ophthalmologist. And they can lead to a sight-threatening condition that requires ...
[14]
Will high myopia ever stabilize and if so, at what age does this ...
Nov 3, 2021 · While this condition can increase the risk of retinal detachment, degenerative changes in the retina, vitreous floaters, cataracts, or glaucoma ...Missing: prominent | Show results with:prominent
[15]
To Treat—or Not to Treat—Vitreous Floaters
Mar 1, 2018 · Vitreous floaters may occur following a retinal tear, retinopexy, scleral buckling, or vitreous hemorrhage associated with a tear.Missing: prominent | Show results with:prominent
[16]
Retinal Detachment: Symptoms & Causes - Cleveland Clinic
a sudden increase in eye floaters, flashes of light or darkening of your vision — get care right away. Call your eye ...
[17]
Retinal Detachment Clinical Presentation - Medscape Reference
Jul 12, 2024 · Generally, the new onset of floaters associated with flashing lights is highly suggestive of a retinal tear. While symptoms of photopsia and ...Missing: warning | Show results with:warning<|control11|><|separator|>
[18]
Retinal Tears - Patients - The American Society of Retina Specialists
A patient with an acute retinal tear may experience the sudden onset of black spots or “floaters” in the affected eye. This can have the appearance of someone ...Missing: warning | Show results with:warning
[19]
Retinal Pathology in Patients with Acute Onset Flashes and Floaters
All patients had floaters and/or flashes of suspected ophthalmologic origin and suspected or diagnosed PVD. The prevalence of retinal tear was 14%.Missing: sudden | Show results with:sudden
[20]
Vitreous Hemorrhage - StatPearls - NCBI Bookshelf - NIH
A patient with vitreous hemorrhage may present with complaints of floaters, haziness, perception of shadows, or cobwebs. It is usually painless. Visual acuity ...Etiology · History and Physical · Treatment / Management · Prognosis
[21]
Uveitis and Glaucoma: Is there a Connection?
Aug 16, 2021 · The most common symptoms of uveitis are eye redness, pain, light sensitivity, floaters, and blurry vision. It can affect one eye or both eyes, ...
[22]
Acute-onset floaters and flashes: is this patient at risk for retinal ...
Nov 25, 2009 · Primary care physicians should evaluate patients with acute-onset floaters and/or flashes due to suspected PVD, or patients with known PVD ...
[23]
Vitreous Antioxidants, Degeneration, and Vitreo-Retinopathy
Dec 20, 2019 · The vitreous body is subdivided into 3 broad anatomical regions: vitreous cortex (anterior and posterior), central vitreous, and vitreous base.
[24]
Vitreous Humor: Composition, Characteristics and Implication on ...
Hyaluronic acid is vulnerable to enzymatic degradation by hyaluronidases ... vitreous could be attributed to relation of the collagen and hyaluronic acid matrix.
[25]
Flashes & Floaters - ERIE RETINAL SURGERY
The reported prevalence of PVD increases from 24% in adults aged 50 to 59 years, 37% amongst those 60-69 years, 59% amongst those 70 to 79 years, to 87% amongst ...
[26]
Spontaneous posterior vitreous detachment: A glance at the current ...
May 20, 2021 · Among patients aged 50-59 years, there is a prevalence of about 24%, which increases to about 87% those 80-90 years of age[1,2].
[27]
Posterior Vitreous Detachment - StatPearls - NCBI Bookshelf
Posterior vitreous detachment (PVD) is the separation of the posterior vitreous cortex and the internal limiting membrane of the retina and is the most common ...
[28]
Posterior Vitreous Detachment, Retinal Breaks, and Lattice ...
Posterior vitreous detachment (PVD) is a separation of the posterior vitreous cortex from the internal limiting membrane of the retina. ... Weiss ring ...
[29]
Posterior Vitreous Detachment: Clinical Correlations
Oct 1, 2004 · ... posterior vitreous detachment. ... Similar figures were reported by Cibis [23](75% of subjects over 65 years), Friedman et al.
[30]
Symptomatic posterior vitreous detachment and the incidence of ...
The incidence of retinal tears in eyes with a symptomatic PVD was 8.2%. The overall rate of retinal break in the meta-analysis portion of the study was 21.7%.
[31]
Myopia as a risk factor for subsequent retinal tears in the course of a ...
Dec 1, 2017 · Multiple retinal tears may be diagnosed in the evolution of a PVD. SRT are most frequently observed in myopic patients, and are usually symptomatic.
[32]
Surgical Considerations For Vitreous Opacities - Retina Today
Symptoms of photopsias and floaters after a posterior vitreous detachment often resolve within 3 to 6 months, obviating the need for any further intervention in ...
[33]
Spontaneous posterior vitreous detachment: A glance at the current ...
Spontaneous posterior vitreous detachment (PVD) is a common age-related condition in patients older than 45 years. Among patients aged 50-59 years, there is a ...
[34]
Retinal Detachment | National Eye Institute - NIH
Dec 10, 2024 · Symptoms: A sudden increase in floaters (small dark spots or squiggly lines that float across your vision), flashes of light in one eye or both ...
[35]
What Are Floaters and Flashes?
Oct 24, 2024 · Floaters are tiny clumps of gel or cells inside the vitreous that fills your eye. What you see are the shadows these clumps cast on your retina.<|separator|>
[36]
Acute-onset floaters and flashes - PMC - NIH
Posterior vitreous detachment is the most common cause of acute-onset floaters or flashes of light. Its prevalence is 24% among adults aged 50–59 years.
[37]
Uveitis | National Eye Institute - NIH
Dec 4, 2024 · Floaters (small dark spots or squiggly lines that float across your vision); Eye pain; Red eyes; Sensitivity to light. If you notice these ...Missing: humor | Show results with:humor
[38]
What Is Uveitis? - American Academy of Ophthalmology
Dec 3, 2024 · Uveitis is inflammation of the uvea, the middle layer of the ... seeing “floaters” (specks or moving clouds in your vision) all of a sudden.
[39]
Uveitis - StatPearls - NCBI Bookshelf - NIH
Intermediate uveitis is not usually associated with pain but can cause blurred vision and floaters, while posterior uveitis more often presents with vision ...
[40]
Endophthalmitis - StatPearls - NCBI Bookshelf - NIH
... floaters. Bleb-related endophthalmitis initially presents as bacterial conjunctivitis with signs and symptoms such as conjunctival hyperemia and discharge ...
[41]
Asteroid Hyalosis: An Update on Prevalence, Risk Factors ...
Jun 20, 2023 · Today, a growing body of epidemiologic data estimates the global prevalence of asteroid hyalosis to be around 1%, and there is a strong ...
[42]
Asteroid Hyalosis (AH) - EyeWiki
Sep 18, 2025 · ... Eye Study and 1.2% prevalence which reported in the U.S. Beaver Dam Eye Study. The estimate prevalence of AH in Seoul, Korea is 0.36%.
[43]
Comparison of Floaters after Cataract Surgery with Different ... - NIH
Jan 1, 2018 · With new-onset floaters · POD 1week, 14 (12.5%) ; With new-onset floaters · POD 1month, 10 (8.93%) ; With new-onset floaters · POD 2months, 8 (7.14%) ...
[44]
Are Floaters After Cataract Surgery Normal? - Lake Eye Associates
Oct 19, 2022 · Yes, floaters are normal after cataract surgery for many patients. These small gray spots or specks in your vision often occur due to changes in ...
[45]
Ocular melanoma: an overview of the current status - PMC - NIH
The most common symptoms are blurred vision, visual field defect, photopsia, irritation and pain, but symptoms as metamorphopsia, floaters, redness and pressure ...
[46]
Ocular Melanoma - StatPearls - NCBI Bookshelf
May 2, 2024 · ... tumor or adjacent structures produces vitreous hemorrhage or hyphema, leading to floaters.[11]. Physical Examination. Choroidal melanoma: ...
[47]
Diabetic Retinopathy: Causes, Symptoms, Treatment
Oct 11, 2024 · This is called neovascularization. These fragile new vessels often bleed into the vitreous. If they only bleed a little, you might see a few ...Proliferative Diabetic... · Diabetic Retinopathy Symptoms
[48]
Diabetic Retinopathy - StatPearls - NCBI Bookshelf - NIH
As the disease progresses, the symptoms include blurred vision, distorted vision, floaters, and partial or total vision loss. Signs seen in diabetic retinopathy ...
[49]
Flashes and floaters: a practical approach to assessment ... - RACGP
Pathophysiology. Floaters refer to the sensation of dark spots that are caused either by opacities in the vitreous, which cast shadows on the retina, or by ...Posterior Vitreous... · Retinal Tear · Retinal Detachment
[50]
Eye floaters - Diagnosis and treatment - Mayo Clinic
Jul 2, 2024 · Most eye floaters don't require treatment. However, any medical condition that is the cause of eye floaters, such as bleeding from diabetes or inflammation, ...
[51]
Eye Emergencies | AAFP
Nov 1, 2020 · Patients with symptomatic floaters and flashing lights should be referred to an ophthalmologist for a dilated funduscopic examination to ...
[52]
ROLE OF OPTICAL COHERENCE TOMOGRAPHY IN ... - PubMed
Mar 1, 2023 · Optical coherence tomography imaging is an emerging standard of care in the setting of patients presenting with new flashes and floaters.
[53]
USE OF OPTICAL COHERENCE TOMOGRAPHY IN DETECTING ...
May 1, 2023 · The presence of PVOs on optical coherence tomography is suggestive of a retinal tear in patients with acute, symptomatic PVD.
[54]
Pictorial essay: B-scan ultrasonography in ocular abnormalities - PMC
B-scan ultrasonography (USG) is a simple, noninvasive tool for diagnosing lesions of the posterior segment of the eyeball. Common conditions such as cataract, ...
[55]
Sonography of the Eye | AJR - American Journal of Roentgenology
The causes of vitreous hemorrhage include vitreous detachment, diabetic retinopathy, retinal microaneurysm, trauma, and vascular tumors. The patient complains ...<|separator|>
[56]
Visualization of retinal breaks on ultra-widefield fundus imaging ...
Nov 9, 2022 · Residents were able to correctly identify more retinal breaks on fundus photos with a green filter overlay compared to photos with traditional ...
[57]
Fluorescein Angiography - StatPearls - NCBI Bookshelf - NIH
Aug 25, 2023 · Fundus fluorescein angiography (FFA) is an invasive diagnostic procedure. It helps to assess the anatomy, physiology, and pathology of retinal and choroidal ...
[58]
Ultra-widefield Imaging Detects 83% of Peripheral Retinal Breaks
Sep 24, 2025 · The findings revealed that UWFI successfully detected 83% of peripheral retinal breaks overall, with sensitivity rising to 96.9% when peripheral ...
[59]
EVALUATING ULTRA-WIDEFIELD IMAGING UTILITY IN ... - PubMed
Jan 1, 2024 · UWF imaging showed a moderate sensitivity and high specificity in detecting treatment-requiring retinal tears and holes, with high interrater agreement.
[60]
How to reduce eye floaters naturally - All About Vision
Oct 6, 2020 · Be sure to dim indoor lights when they are too bright for your eyes or use lamps instead of overheads. On the contrary, if you're trying to read ...<|separator|>
[61]
Living with Flashes and Floaters Coping Strategies and Treatment ...
Nov 30, 2023 · - Use sufficient ambient lighting to make floaters less noticeable. - Avoid fixation on symptoms by focusing gaze on the object of interest, ...
[62]
Sinking the Floaters - Review of Optometry
Feb 15, 2020 · This article describes the development of these pesky floaters, what patients can achieve from undergoing a procedure to address them, how to co-manage ...
[63]
Posterior vitreous detachment and retinal tear – a prospective study ...
Oct 5, 2023 · We found a retinal tear rate of 8.8% of patients with photopsia and floaters and in 9.9% of all PVDs. Other studies have found rates of PVD- ...Missing: sudden | Show results with:sudden
[64]
Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of ...
Feb 21, 2020 · This review article presents selected pertinent evidence on the efficacy and safety of YAG laser vitreolysis, highlights possible explanations for the ...
[65]
Laser Vitreolysis - EyeWiki
May 19, 2025 · The first report of YAG laser vitreolysis for floaters was ... floaters will only be fragmented, and the success rate will be quite low.Introduction · Indications · Procedure · Complications
[66]
Long-term efficacy and safety of YAG laser vitreolysis for vision ... - NIH
Totally 57.01% of patients experienced a significant improvement in their floater symptoms after YAG laser therapy, and none of them developed delayed retinal ...
[67]
Point-Counterpoint: Should YAG Vitreolysis for Symptomatic and ...
Feb 27, 2024 · A posterior vitreous detachment is present in approximately 50% of patients by the age of 50 years and 65% of patients by the age of 65 years.1 ...<|control11|><|separator|>
[68]
Low-Dose 0.01% Atropine Eye Drops for Symptomatic Vitreous ...
Aug 20, 2025 · If a therapeutic effect is established, low-dose atropine could be a safe treatment option for symptomatic floaters.
[69]
Low-Dose Atropine Drops: Safe Treatment for Floaters | ASRS 2025
Aug 1, 2025 · The off-label use of 0.01% atropine drops is a safe and noninvasive way to treat symptomatic vitreous floaters, according to a study done by ...
[70]
0.01% Atropine for the Treatment of Vitreous Floaters
Sep 25, 2025 · We concluded that low dose atropine can be an effective and noninvasive treatment option for individuals with persistently symptomatic vitreous ...
[71]
Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction ...
Aug 16, 2012 · Our data support the finding that intravitreal injection of ocriplasmin leads to resolution of vitreomacular traction, induction of posterior ...
[72]
Ocriplasmin Update: Safety, Efficacy, and Usage
Oct 1, 2012 · After more than a decade of testing, it is poised to become the first FDA-approved agent for pharmacologic vitreolysis.
[73]
Specialists deliberate criteria, best practices, benefits and risks of ...
Mar 20, 2025 · Vitreous floaters are a common ocular condition, affecting up to 76% of the population, according to Webb and colleagues.
[74]
Pars plana vitrectomy for vitreous floaters: Is there such a thing as ...
Their high surgical success rate was based on 94% of patients ... risk of blindness to get rid themselves of symptoms associated with vitreous floaters.
[75]
Efficacy and Safety of Pars Plana Vitrectomy for Primary ...
This study aimed to determine the efficacy and safety of pars plana vitrectomy (PPV) as treatment for patients with primary symptomatic vitreous floaters.
[76]
Good results reported with PPV for floaters but risks questioned
Sep 23, 2014 · In the first study, a retrospective review of 168 eyes of 143 patients, the authors reported a high surgical success rate with 94% of patients ...Missing: indications | Show results with:indications
[77]
Small-Gauge Pars Plana Vitrectomy for Visually Significant Vitreous ...
This article evaluates our experience at a retina-only private practice with small-gauge pars plana vitrectomy (PPV) for visually significant vitreous floaters.Missing: details | Show results with:details
[78]
A Comparative Study of 23-Gauge and 27-Gauge Vitrectomy ... - NIH
Eighty patients who were scheduled to undergo pars plana vitrectomy (PPV) for floaters or macular surgery were treated with either 27-gauge or 23-gauge ...
[79]
Outcomes of pars plana vitrectomy for visually significant floaters in ...
May 6, 2025 · Numerous studies have found that pars plana vitrectomy is effective at reducing or resolving floater-associated symptoms with high patient ...
[80]
Management Options for Symptomatic Vitreous Floaters
In some instances, floaters may be indicative of more sinister pathology, such as malignancies in the case of masquerade syndromes. Clinicians therefore need ...Review Article · Keywords · VitrectomyMissing: classification physiological
[81]
Pars Plana Vitrectomy - EyeWiki
Sep 18, 2025 · David Kasner first described vitrectomy, or removal of the vitreous body, using an open-sky technique in 1969. Two years later, Robert Machemer ...
[82]
Floater Stories: Assessing the Potential Benefits of Vitrectomy
Jun 5, 2024 · Why did nearly three decades elapse between the advent of pars plana vitrectomy and the first publication, in the year 2000, of its use to ...
[83]
Vitrectomy for Vitreous Floaters | Retinal Physician
May 1, 2015 · Until recently, the customary treatment for floaters was limited to three- or four-port pars plana vitrectomy. Modern 20- to 27-gauge three- or ...<|control11|><|separator|>
[84]
Prevalence of vitreous floaters in a community sample of ... - NIH
Floater prevalence was not significantly affected by respondent age, race, gender, and eye color. CONCLUSION. Vitreous floaters were found to be a very common ...
[85]
Treatment for Eye Flashes & Eye Floaters - The Retina Eye Center
Research suggests that PVD prevalence increases from 24 percent in adults 50-59 to 87 percent in those 80-89 years. But unless associated with an eye disease, ...
[86]
Mayo Clinic Q and A: Most eye floaters caused by age-related ...
Nov 13, 2022 · Eye floaters are black or gray specks, strings, or cobwebs that typically drift about when you move your eyes and appear to dart away when ...
[87]
Is it Normal for Young People With Myopia to Have Eye Floaters?
Apr 19, 2022 · People with myopia were 3.5 X more likely to have floaters than those with normal vision in this study. How old or young an individual was did ...
[88]
Prevalence, Risk Factors and Quality of Floaters Among Medical ...
Jun 22, 2021 · ... floater with flashes (6%) and patients with floaters, flashes, and blurred vision was 5%. Myopia was the most common refraction problem.
[89]
https://www.researchgate.net/publication/352646899_Prevalence_Risk_Factors_and_Quality_of_Floaters_Among_Medical_Students_A_Questionnaire-Based_Study
[90]
Knowledge, attitudes, and practices regarding floaters among patients
Jul 8, 2025 · Ocular floaters' prevalence ranges from 27 to 63%, exerting a considerable impact on individuals' overall wellbeing (3). A study revealed a 76% ...
[91]
Posterior Vitreous Detachment - an overview | ScienceDirect Topics
Autopsy studies revealed an incidence of 27–51% in the seventh decade and 63% in the eighth decade. It is not certain, however, that these are not overestimates ...
[92]
The Blue Mountains Eye Study - PubMed
Apr 19, 2021 · Results: Overall, 451 participants showed any VRI abnormality (49.8%). Prevalence of VRI abnormality by person was: vitreomacular adhesion (VMA) ...Missing: floaters | Show results with:floaters
[93]
Posterior Vitreous Detachment in Highly Myopic Patients - PMC
Apr 25, 2020 · Posterior vitreous detachment (PVD) is associated with serious ocular pathologies, including retinal tears, rhegmatogenous retinal detachment, ...
[94]
An Impending Posterior Vitreous Detachment (PVD)
Nov 17, 2014 · Symptoms of a hemorrhagic PVD may include a more significant decrease in vision secondary to the blood dispersed throughout the vitreous cavity.<|control11|><|separator|>
[95]
An In-Depth Review on Cigarette Smoking and Its Impact on Ocular ...
Oct 27, 2023 · Smoke from cigarettes contains harmful substances and reactive oxygen species that can cause oxidative damage and cause lens opacity. Smoking ...
[96]
[PDF] Eye Floaters: When Should You Be Concerned?
Regardless, most floaters become less visible as time goes on. When Should You be Concerned About Floaters? There are several factors to consider that ...
[97]
Posterior Vitreous Detachment - Patients
Posterior Vitreous Detachment (PVD) is a natural change that occurs during adulthood, when the vitreous gel that fills the eye separates from the retina.Missing: synovial- | Show results with:synovial-
[98]
UV, HEV And The Aging Eye - 20/20 Magazine
There is some evidence that UV has an effect on making the vitreous more liquid, with floaters becoming more numerous and contributing to a posterior vitreal ...
[99]
Dietary Intervention With a Targeted Micronutrient Formulation ...
Oct 14, 2021 · Vitreous degeneration culminates in vitreous floaters, the perception of linear strands and dark grey spots primarily within the central visual ...Missing: classification | Show results with:classification
[100]
Can Eye Floaters Be a Sign of Systemic Health Issues?
This inflammation can lead to the release of inflammatory debris into the vitreous, which is seen as floaters.
[101]
The association of symptomatic vitreous floaters with depression ...
May 7, 2024 · Conclusion: Vitreous floaters have a negative impact on patients' psychological status, by the terms of enhanced depressive and anxiety levels.
[102]
Why Eye Floaters Can Worsen Anxiety | Psychology Today
Jan 16, 2025 · Eye floaters are a harmless visual quirk. However, for those dealing with anxiety, floaters can become a significant source of distress.
[103]
Psychological Distress in Patients with Symptomatic Vitreous Floaters
We found that symptomatic vitreous floater patients suffered more psychological problems, such as depression, stress, and anxiety compared to control group.
[104]
Psychological implications of vitreous opacities – A systematic review
Patients with vitreous opacities showed significantly higher levels of symptoms of depression, perceived stress, state anxiety, and trait anxiety.
[105]
The effectiveness of laser vitreolysis for vitreous floaters
Twelve patients had both eyes lasered and 33 patients had one eye lasered. The mean CSF improved from 3.20 ± 0.85%W to 2.64 ± 0.63%W 1 month after vitreolysis.
[106]
The impact of vitreous floaters on quality of life: a qualitative study
Aug 18, 2025 · Many people perceive vitreous floaters, with self-reported prevalence levels reaching 87% of the general population, but not everyone is ...Missing: incidence | Show results with:incidence
[107]
Patient-reported outcomes in patients with vitreous floaters
In this review, we focus on floaters caused by age-related vitreous syneresis. ... Prevalence of vitreous floaters in a community sample of smartphone users.
[108]
How Eye Floaters Can Impact Your Vision and Quality of Life
Nov 20, 2024 · Eye strain can cause discomfort, headaches, and fatigue, reducing productivity and making recreational activities less enjoyable. Floaters can ...Missing: social | Show results with:social
[109]
Vision degrading myodesopsia from vitreous floaters in the young
Floaters are visual phenomena caused by aggregated vitreous collagen fibers. Affected patients describe floaters as squiggly, worm-like strands, aggregates or ...
[110]
Why are some patients less able to adapt to floaters and report ...
Mar 20, 2025 · Rarely, they could express suicidal ideation solely because of floaters, despite 20/20 vision in both eyes. Following surgical vitrectomy, ...
[111]
Safer Eye Floater Treatments Come with a Burst of Nanobubbles
May 6, 2022 · With a safer and less invasive nanoparticle-based therapy, people with floaters may finally get their vision and quality of life back.
[112]
Induction of posterior vitreous detachment (PVD) by non-enzymatic ...
May 19, 2020 · Ocriplasmin has been the only FDA-approved clinical reagent so far. Several adverse effects of ocriplasmin have emerged, however, and the search ...
[113]
OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL ...
The INJECT study showed that ocriplasmin is effective in a clinical setting in patients with VMT, with or without MH.Missing: analogs II
[114]
Automated Detection of Posterior Vitreous Detachment on OCT ...
To develop automated algorithms for the detection of posterior vitreous detachment (PVD) using OCT imaging. Evaluation of a diagnostic test or technology.
[115]
Ultrasonographic evaluation of vitreous degeneration in normal dogs
Vitreous degeneration was found in 20% (23/114) of the eyes on ultrasonographic examination but in only 8% (9/114) of eyes on direct ophthalmoscopy. Sensitivity ...
[116]
Ocular ultrasonography – part 1 - Vet Times
Jan 18, 2022 · The use of ocular ultrasonography has become a standard imaging technique in veterinary ophthalmology. It is used routinely to evaluate ocular and orbital ...
[117]
Ocular ultrasonography and echobiometry findings in dogs affected ...
B-mode ultrasonography proved to be an invaluable tool in diagnosing and managing vitreoretinal diseases, helping in preventing severe visual impairment.
[118]
Diseases and Surgery of the Canine Posterior Segment - Veterian Key
Oct 22, 2022 · Floaters of hemorrhagic or other exudate in the vitreous, especially if diffuse or bilateral, often result from exudative uveitis, ...<|separator|>
[119]
Vitreoretinal surgery | Veterian Key
Oct 14, 2016 · Pars plana vitrectomy is indicated for deeper vitreal opacities, including hemorrhages, treatment of malignant glaucoma, treatment for vitreous ...
[120]
Vitrectomy in Dogs - Conditions Treated, Procedure, Efficacy ... - Wag!
Vitrectomy is done to treat complete retinal detachment as well as severe retinal tears. These are often caused by congenital disease and traumatic injury.
[121]
Managing Uveitis in Dogs and Cats | Today's Veterinary Practice
Uveitis management aims to control inflammation, reduce pain, preserve vision, and resolve underlying issues. Treatment includes anti-inflammatories, ...
[122]
Uveitis in Dogs | VCA Animal Hospitals
Treatment is initially aimed at reducing inflammation and providing pain relief, primarily with topical eye medications such as corticosteroids (prednisolone, ...Missing: floaters | Show results with:floaters
[123]
Eye Can See Clearly Now: Vitreal Floaters in Pets
May 8, 2021 · Vitreal floaters are a common age-related eye condition in pets. We discuss diagnosis, signs, and treatment in pets.